1. Home
  2. |Insights
  3. |ACI's FDA Boot Camp

ACI's FDA Boot Camp

Event | 05.29.08 - 05.30.08, 12:00 AM UTC - 12:00 AM UTC

ACI’s FDA Boot Camp has been designed to give products and patent litigators, as well as patent prosecutors and life sciences investment and securities experts, a strong working knowledge of core FDA competencies, including the nuances of FDAAA.

A distinguished faculty of top FDA regulatory experts — a “Who’s Who of the FDA Bar” — will share their knowledge and offer insights into the critical aspects of the commercialization process for drugs, biologics, and devices that are governed by FDA law and regulation.

Dick Downing will discuss Trademark Issues during the "Patent and IP Overview: Hatch-Waxman, Trademark Protection, and More" session.

For more information, please visit these areas: Intellectual Property Litigation, Intellectual Property

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.